Brief: Medexus Granted Priority Review Status For Gliolan By Health Canada

Medexus Pharmaceuticals

19/11/2019 13:53

Nov 19 (Reuters) - Medexus Pharmaceuticals Inc  MDP.V :
    * MEDEXUS GRANTED PRIORITY REVIEW STATUS FOR GLIOLAN® BY
HEALTH
CANADA
    * MEDEXUS PHARMACEUTICALS INC -  ANTICIPATES FILING NDS IN
2019
FOR APPROVAL TO MARKET AND SELL GLIOLAN IN CANADA

Source text for Eikon:  ID:nGNX6DRTP1 
Further company coverage:  MDP.V 

 ((Briefs@thomsonreuters.com;))